{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:09:44Z","timestamp":1740164984900,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences","doi-asserted-by":"publisher","award":["2022IF0008"],"award-info":[{"award-number":["2022IF0008"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2018R1C1B6008884"],"award-info":[{"award-number":["NRF-2018R1C1B6008884"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018528","name":"Korean Neurological Association","doi-asserted-by":"publisher","award":["KNA-21-SK-15,16"],"award-info":[{"award-number":["KNA-21-SK-15,16"]}],"id":[{"id":"10.13039\/100018528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["H18C0016"],"award-info":[{"award-number":["H18C0016"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.msard.2024.105551","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T23:40:15Z","timestamp":1710978015000},"page":"105551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Blood sphingolipid as a novel biomarker in patients with neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"85","author":[{"given":"Hyunjin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungmin","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Yon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Jae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayoung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Eun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Min","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Ju","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8047-1029","authenticated-orcid":false,"given":"Eun-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105551_bib0006","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ana.26067","article-title":"Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker","volume":"89","author":"Aktas","year":"2021","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.msard.2024.105551_bib0031","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbi.2015.02.010","article-title":"Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophils","volume":"46","author":"Barthelmes","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.msard.2024.105551_bib0024","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95302","article-title":"Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation","volume":"2","author":"Bhargava","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.msard.2024.105551_bib0021","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol"},{"key":"10.1016\/j.msard.2024.105551_bib0019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-019-1436-1","article-title":"Astrocytic ceramide as possible indicator of neuroinflammation","volume":"16","author":"de Wit","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2024.105551_bib0030","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/icb.2015.47","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation\/migration of neutrophils","volume":"93","author":"Eberle","year":"2015","journal-title":"Immunol. Cell Biol"},{"key":"10.1016\/j.msard.2024.105551_bib0032","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.biocel.2011.12.019","article-title":"Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth","volume":"44","author":"Hartmann","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.msard.2024.105551_bib0026","doi-asserted-by":"crossref","unstructured":"Henseler J., Ringle C. and Sinkovics R. The use of partial least squares path modeling in international marketing. 2009, pp.277\u2013319.","DOI":"10.1108\/S1474-7979(2009)0000020014"},{"key":"10.1016\/j.msard.2024.105551_bib0001","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3988\/jcn.2022.18.2.152","article-title":"An update on the laboratory diagnosis of neuromyelitis optica spectrum disorders","volume":"18","author":"Jeyalatha","year":"2022","journal-title":"J. Clin. Neurol"},{"key":"10.1016\/j.msard.2024.105551_bib0012","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/jnnp-2021-326487","article-title":"GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance","volume":"92","author":"Katisko","year":"2021","journal-title":"J. Neurol. Neurosurg. Psych."},{"key":"10.1016\/j.msard.2024.105551_bib0014","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat. Commun"},{"key":"10.1016\/j.msard.2024.105551_bib0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000708","article-title":"Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"7","author":"Kim","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"10.1016\/j.msard.2024.105551_bib0003","article-title":"Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder","author":"Kim","year":"2021","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2024.105551_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103500","article-title":"Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: cross-sectional and longitudinal analysis","volume":"58","author":"Kim","year":"2022","journal-title":"Mult. Scler Relat. Disord"},{"key":"10.1016\/j.msard.2024.105551_bib0004","article-title":"Glial fibrillary acidic protein in blood as a disease biomarker of neuromyelitis optica spectrum disorders","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Neurol"},{"key":"10.1016\/j.msard.2024.105551_bib0008","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1038\/s41598-023-32748-5","article-title":"Serum proteins for monitoring and predicting visual function in patients with recent optic neuritis","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep"},{"key":"10.1016\/j.msard.2024.105551_bib0009","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1038\/s41598-023-30755-0","article-title":"Disease characteristics of idiopathic transverse myelitis with serum neuronal and astroglial damage biomarkers","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep"},{"key":"10.1016\/j.msard.2024.105551_bib0013","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/acn3.51070","article-title":"Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases","volume":"7","author":"Lee","year":"2020","journal-title":"Ann. Clin. Transl. Neurol"},{"key":"10.1016\/j.msard.2024.105551_bib0011","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13054-015-1081-8","article-title":"Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study","volume":"19","author":"Lei","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.msard.2024.105551_bib0016","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.msard.2024.105551_bib0025","first-page":"239","article-title":"A practical application of a simple bootstrapping method for assessing predictors selected for epidemiologic risk models using automated variable selection","volume":"7","author":"Mannan","year":"2017","journal-title":"Int. J. Statist. Applic."},{"key":"10.1016\/j.msard.2024.105551_bib0033","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/glia.20292","article-title":"Sulfatide is essential for the maintenance of CNS myelin and axon structure","volume":"53","author":"Marcus","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.msard.2024.105551_bib0027","first-page":"633","article-title":"Serum ceramides increase the risk of Alzheimer disease","volume":"79","author":"Mielke","year":"2012","journal-title":"Women's Heal. Aging Study II"},{"key":"10.1016\/j.msard.2024.105551_bib0017","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/PL00000836","article-title":"Sphingolipids in mammalian cell signalling","volume":"58","author":"Ohanian","year":"2001","journal-title":"Cell Mol. Life Sci"},{"key":"10.1016\/j.msard.2024.105551_bib0015","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170069","article-title":"Sphingolipids: membrane microdomains in brain development, function and neurological diseases","volume":"7","author":"Olsen","year":"2017","journal-title":"Open Biol"},{"key":"10.1016\/j.msard.2024.105551_bib0022","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.msard.2024.105551_bib0018","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nm.3719","article-title":"Astrocyte-derived lactosylceramide implicated in multiple sclerosis","volume":"20","author":"Rostami","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2024.105551_bib0023","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/01.wnl.0000253185.03943.66","article-title":"Longitudinal follow-up of \"benign\" multiple sclerosis at 20 years","volume":"68","author":"Sayao","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105551_bib0007","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12974-021-02138-7","article-title":"Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder","volume":"18","author":"Schindler","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2024.105551_bib0035","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/jnr.22003","article-title":"Adult CST-null mice maintain an increased number of oligodendrocytes","volume":"87","author":"Shroff","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.msard.2024.105551_bib0034","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1194\/jlr.R026682","article-title":"Role of sulfatide in normal and pathological cells and tissues","volume":"53","author":"Takahashi","year":"2012","journal-title":"J. Lipid. Res"},{"key":"10.1016\/j.msard.2024.105551_bib0029","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/brain\/awab102","article-title":"Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders","volume":"144","author":"Takai","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2024.105551_bib0028","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","article-title":"Fingolimod attenuates ceramide-induced blood\u2013brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes","volume":"124","author":"van Doorn","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2024.105551_bib0005","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","article-title":"Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD","volume":"93","author":"Watanabe","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105551_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:41:04Z","timestamp":1738064464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824001305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":35,"alternative-id":["S2211034824001305"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105551","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood sphingolipid as a novel biomarker in patients with neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105551"}}